Literature DB >> 8600394

Impaired migration but not differentiation of haematopoietic stem cells in the absence of beta1 integrins.

E Hirsch1, A Iglesias, A J Potocnik, U Hartmann, R Fässler.   

Abstract

Adhesive interactions mediated by integrins of the beta1 subfamily are thought to be critical in controlling differentiation and migration of blood cell precursors. Here we report that chimaeric mice generated with beta1-integrin-deficient embryonic stem (ES) cells lack beta1(-/-) cells in blood and in haematopoietic organs such as spleen, thymus and bone marrow. Chimaeric embryos contain beta1-null haematopoietic cells in the yolk sac and in fetal blood but not in fetal liver. We show that such beta1(-/-) haematopoietic stem cells derived from yolk sac of 10.5-day-old chimaeric embryos readily generate erythroid and myeloid colonies and that beta1(-/-) ES cells can differentiate into mature B lymphocytes in vitro. Our results indicate that haematopoietic stem cells lacking beta1 integrins can form and differentiate into different lineages but cannot colonize the fetal liver.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8600394     DOI: 10.1038/380171a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  74 in total

1.  Rac and Cdc42 GTPases control hematopoietic stem cell shape, adhesion, migration, and mobilization.

Authors:  F C Yang; S J Atkinson; Y Gu; J B Borneo; A W Roberts; Y Zheng; J Pennington; D A Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

2.  An essential role in liver development for transcription factor XBP-1.

Authors:  A M Reimold; A Etkin; I Clauss; A Perkins; D S Friend; J Zhang; H F Horton; A Scott; S H Orkin; M C Byrne; M J Grusby; L H Glimcher
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

3.  Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on beta1-integrin to promote normal liver development.

Authors:  M Weinstein; S P Monga; Y Liu; S G Brodie; Y Tang; C Li; L Mishra; C X Deng
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

4.  Evidence that β7 Integrin Regulates Hematopoietic Stem Cell Homing and Engraftment Through Interaction with MAdCAM-1.

Authors:  Jodi L Murakami; Baohui Xu; Christopher B Franco; Xingbin Hu; Stephen J Galli; Irving L Weissman; Ching-Cheng Chen
Journal:  Stem Cells Dev       Date:  2015-11-05       Impact factor: 3.272

5.  beta1- and alpha6-integrin are surface markers on mouse spermatogonial stem cells.

Authors:  T Shinohara; M R Avarbock; R L Brinster
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 6.  Targeting the leukemic stem cell: the Holy Grail of leukemia therapy.

Authors:  N Misaghian; G Ligresti; L S Steelman; F E Bertrand; J Bäsecke; M Libra; F Nicoletti; F Stivala; M Milella; A Tafuri; M Cervello; A M Martelli; J A McCubrey
Journal:  Leukemia       Date:  2008-09-18       Impact factor: 11.528

Review 7.  Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.

Authors:  M P Rettig; G Ansstas; J F DiPersio
Journal:  Leukemia       Date:  2011-09-02       Impact factor: 11.528

8.  PI3K is involved in β1 integrin clustering by PSGL-1 and promotes β1 integrin-mediated Jurkat cell adhesion to fibronectin.

Authors:  Jixian Luo; Chunfeng Li; Tingshuang Xu; Wenai Liu; Xueqing Ba; Xiaoguang Wang; Xianlu Zeng
Journal:  Mol Cell Biochem       Date:  2014-01       Impact factor: 3.396

9.  Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins.

Authors:  D D Schlaepfer; M A Broome; T Hunter
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

10.  VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin.

Authors:  J C van der Loo; X Xiao; D McMillin; K Hashino; I Kato; D A Williams
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.